Safety of Blind Percutaneous Liver Biopsy in Obese Children A Retrospective Analysis
Authors:
- 1 November 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 44 (10) , e253-e255
Abstract
Goal To determine the safety and adequacy of blind percutaneous liver biopsy (PLB) in obese children. Background PLB is an important diagnostic tool that, while invasive, enjoys a relatively low major complication rate. An ever increasing reason for pediatric liver biopsy is nonalcoholic fatty liver disease associated with obesity. There is a lack of data assessing the safety of liver biopsy in obese compared to nonobese children. Study A retrospective study of all children over 5 years of age having PLB was conducted. Data collected included age, gender, weight, height, BMI, reason for biopsy, number of passes, biopsy length, number of portal triads per biopsy, and complication rates. Results A total of 107 biopsies were reviewed. All biopsies were successful. Overall, major complications occurred in 1.3% and minor complications in 8.4%; there were no deaths. Comparison revealed no difference for number of passes (1.5±0.7 vs. 1.7±0.7), biopsy length (2.0±1.3 cm vs. 1.5±1.1 cm), number of portal tracts per biopsy (9.8±5.8 vs. 9.9±3.4), or complication rates (major: 0% vs. 1.3%; minor: 10.0% vs. 7.8%) between obese and nonobese children. Conclusion Blind PLB can be safely carried out in obese children with no increase in complication rate compared with nonobese children. Similarly, there is no difference in number of passes, biopsy size, portal triads per biopsy, or biopsy success for obese children.Keywords
This publication has 22 references indexed in Scilit:
- Clinical Correlates of Histopathology in Pediatric Nonalcoholic SteatohepatitisGastroenterology, 2008
- Prevalence of Fatty Liver in Children and AdolescentsPediatrics, 2006
- Nonalcoholic Fatty Liver Disease in ChildrenClinics in Liver Disease, 2005
- Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinomaGastroenterology, 2002
- Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked ObesityNew England Journal of Medicine, 2002
- Can One Predict When Ultrasound Will Be Useful With Percutaneous Liver Biopsy?American Journal of Gastroenterology, 2001
- How Often Does Ultrasound Marking Change The Liver Biopsy Site?American Journal of Gastroenterology, 1999
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Complications of percutaneous liver biopsy in childrenGastroenterology, 1992
- Neonatal cholestasisThe Journal of Pediatrics, 1985